(AGENPARL) - Roma, 19 Giugno 2024 - (AGENPARL) – mer 19 giugno 2024 *Source*: Tokyo Institute of Technology
*Immediate release:* June 19, 2024
*Headline*: Transforming Inexpensive Quinolines into Complex Drug Candidates
*Sub-headline: * Scientists develop a cost-effective methodology to produce
various biologically relevant organic compounds from simple feedstock
chemicals.
*(Tokyo, June 19) * An innovative synthesis strategy opened up the way to
2D/3D fused frameworks using inexpensive quinolines as feedstock, report
scientists from Tokyo Tech. By leveraging a light-sensitive borate
intermediate, the scientists could transform quinoline derivatives into a
great variety of 2D/3D fused frameworks in a straightforward and
cost-effective manner. Their findings are expected to enable the synthesis
of highly customizable drug candidates.
For more information, please visit the Tokyo Tech news that we posted at
https://www.titech.ac.jp/english/news/2024/069466 or contact us.
*Figure:* https://tokyotech.box.com/s/4l2k6sbrk2ny3y9g4el6gyj7uuq7a99t
*Contact: *Emiko Kawaguchi, Public Relations Department, Tokyo Institute
*About Tokyo Institute of Technology*
Tokyo Tech stands at the forefront of research and higher education as the
leading university for science and technology in Japan. Tokyo Tech
researchers excel in fields ranging from materials science to biology,
computer science, and physics. Founded in 1881, Tokyo Tech hosts over
10,000 undergraduate and graduate students per year, who develop into
scientific leaders and some of the most sought-after engineers in industry.
Embodying the Japanese philosophy of “monotsukuri,” meaning “technical
ingenuity and innovation,” the Tokyo Tech community strives to contribute
to society through high-impact research.
https://www.titech.ac.jp/english/